Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
$47K Buy
924
+104
+13% +$5.09K 0.02% 147
2015
Q4
$41K Sell
820
-356
-30% -$17.9K 0.02% 146
2015
Q3
$55K Buy
1,176
+262
+29% +$13.9K 0.03% 133
2015
Q2
$50K Hold
914
0.02% 140
2015
Q1
$50K Hold
914
0.02% 139
2014
Q4
$50K Buy
914
+210
+30% +$11.7K 0.02% 139
2014
Q3
$40K Hold
704
0.02% 137
2014
Q2
$39K Sell
704
-7,665
-92% -$418K 0.02% 142
2014
Q1
$453K Sell
8,369
-799
-9% -$41.4K 0.19% 29
2013
Q4
$438K Buy
9,168
+304
+3% +$13.9K 0.19% 30
2013
Q3
$403K Sell
8,864
-302
-3% -$13.8K 0.39% 16
2013
Q2
$406K Buy
+9,166
New +$409K 0.23% 25

Other funds holding MRK

Hoxton Financial's MRK Position: Q1 2016 in Review

Hoxton Financial increased its Merck (MRK) stake by 13% in Q1 2016, buying an estimated $5.09K and bringing the position to 924 shares worth $47K. The position accounts for 0.02% of the portfolio, ranked #147.

Hoxton Financial first reported a position in MRK in Q2 2013 and has held it in 12 quarters since. The position peaked at $453K in Q1 2014. 1,745 funds tracked by Wall St. Rank hold MRK as of Q1 2016.

  • Hoxton Financial held 924 shares of Merck worth $47K as of Q1 2016.
  • Hoxton Financial bought 104 Merck shares in Q1 2016, an estimated $5.09K.
  • Merck made up 0.02% of Hoxton Financial's portfolio in Q1 2016, its #147 holding.
  • Hoxton Financial first reported a position in Merck in Q2 2013 and has held it in 12 quarters since.
  • Hoxton Financial's Merck position peaked at $453K in Q1 2014.
  • 1,745 funds tracked by Wall St. Rank held Merck as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.